Stability-indicating high-performance liquid chromatography of etoposide at various pH conditions using a reversed-phase octyl column

This publication has 12 references indexed in Scilit:

• High-performance liquid chromatography of etoposide in plasma and urine
  Journal of Chromatography B: Biomedical Sciences and Applications, 1985
• Stability-Indicating Liquid Chromatographic Determination of Etoposide and Benzyl Alcohol in Injectable Formulations
  Journal of Pharmaceutical Sciences, 1985
• Determination of etoposide (VP16-213) and teniposide (VM-26) in serum by high-performance liquid chromatography with electrochemical detection
  Journal of Pharmaceutical and Biomedical Analysis, 1984
• High-Performance Liquid Chromatographic Analysis of the Semisynthetic Epipodophyllotoxins Teniposide and Etoposide Using Electrochemical Detection
  Journal of Pharmaceutical Sciences, 1984
• Automated liquid chromatographic analysis of the anti-tumorigenic drugs etoposide (VP 16-213) and teniposide (VM 26)
  Journal of Chromatography B: Biomedical Sciences and Applications, 1983
• High-performance liquid chromatography determination of 4′-demethyl-epipodophyllotoxin-9-(4,6-O-ethylidene β-d-glucopyranoside) (VP 16-213) in human plasma
  Journal of Chromatography B: Biomedical Sciences and Applications, 1981
• Analysis of 4′-demethylepipodophyllotoxin-9-(4,6-o-ethylidene-β-d-glucopyranoside) by high-pressure liquid chromatography
  Journal of Pharmaceutical Sciences, 1980
• Analysis of the anticancer drugs VP 16-213 and VM 26 and their metabolites by high-performance liquid chromatography
  Journal of Chromatography B: Biomedical Sciences and Applications, 1980
• Etoposide (VP-16-213)
  Cancer Treatment Reviews, 1979
• A clinical trial of the oral form of 4′-demethyl-epipodophyllotoxin-β-D ethylidene glucoside (NSC 141540) VP 16–213
  Cancer, 1975